TABLE 1.

Baseline Characteristics at Time of Subfoveal Hemorrhage

	Patients With Subfoveal Hemorrhage (N = 16)
Age (y), mean ± SEM	81.4 ± 2.2
Female, n (%)	9 (56.3)
Race, n (%)
White	15 (93.8)
African American	1 (6.3)
Systemic disease, n (%)
Diabetes mellitus	2 (12.5)
Hypertension	12 (75.0)
Use of anticoagulation	0
Thickness of SFH on SD-OCT (μm), n (%)
<250	2 (12.5)
250–500	11 (68.8)
>500	3 (18.8)
Size of SFH (DA), n (%)
<10	7 (43.8)
10–20	5 (31.3)
>20	4 (25.0)
VA at time of SFH (Snellen), n (%)
20/50 or better	1 (6.3)
20/63 to 20/160	5 (31.3)
20/200 or worse	10 (62.5)
CST at time of SFH (μm), mean ± SEM	591.7 ± 57.0

CST = central subfield thickness; DA = disc area; SD-OCT = spectral-domain optical coherence tomography; SFH = subfoveal hemorrhage; VA = visual acuity.